Status:

UNKNOWN

Investigating the Safety and Clinical Performance of Seven iVascular Devices for Endovascular Intervention in the Popliteal and/or Infrapopliteal Arteries

Lead Sponsor:

iVascular S.L.U.

Collaborating Sponsors:

FCRE (Foundation for Cardiovascular Research and Education)

Conditions:

Peripheral Arterial Disease Below The Knee

Eligibility:

All Genders

18+ years

Brief Summary

The rationale of this study is to confirm and support the clinical safety and performance of the Oceanus 14pro, Oceanus 18 and Oceanus 35 Balloon Catheters, the Luminor 14m and Luminor 18 Drug Coated ...

Eligibility Criteria

Inclusion

  • Corresponding to the CE-mark indications/contra-indications and according to the IFU of the device.
  • Patient is \>18 years old.
  • Patient understands the nature of the procedure and provides written informed consent prior to enrolment in the study.
  • Target lesion(s) is/are located in the popliteal or infrapopliteal arteries
  • Patient is eligible for treatment with the Oceanus 14pro Balloon Catheter and/or the Oceanus 18 Balloon Catheter and/or the Oceanus 35 Balloon Catheter and/or the Luminor 14m DCB and/or the Luminor 18 DCB and/or the Angiolite BTK Sirolimus Eluting Peripheral Stent System and/or the Sergeant Peripheral Support Catheter as described in the IFU for each device.

Exclusion

  • Anatomy or size of vessels that will not allow appropriate usage of the investigational devices, following IFU of the investigational devices.
  • Known contraindication and/or allergy to (a component of) an investigational device.
  • Pregnant women and women with childbearing potential not taking adequate contraceptives or currently breastfeeding.
  • Life expectancy of less than 12 months.
  • Any planned surgical intervention/procedure within 30 days after the study procedure.
  • Any patient considered to be hemodynamically unstable at onset of procedure.

Key Trial Info

Start Date :

May 30 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2025

Estimated Enrollment :

143 Patients enrolled

Trial Details

Trial ID

NCT05267548

Start Date

May 30 2022

End Date

May 1 2025

Last Update

February 3 2023

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Imelda Bonheiden

Bonheiden, Belgium

2

Jessa Hasselt

Hasselt, Belgium

3

Az Groeninge Kortrijk

Kortrijk, Belgium

4

Az Sint Maarten Mechelen

Mechelen, Belgium